Literature DB >> 9236818

Morbidity and mortality due to ascariasis: re-estimation and sensitivity analysis of global numbers at risk.

N R de Silva1, M S Chan, D A Bundy.   

Abstract

This paper presents estimates of the global numbers of people at risk from morbidity related to infection with Ascaris lumbricoides and the numbers of deaths from this infection. Morbidity is classified into 4 types: deficits in growth and fitness which are contemporaneous with infection, or permanent, overt acute illness of mild to moderate severity, and complications involving hospitalization. The estimation of morbidity is based on theoretical models of parasite distributions developed in previous papers. A sensitivity analysis is carried out in which parameters of the model are varied using a Latin hypercube sampling technique. The results estimate approximately 1300 million infections globally with 59 million at risk of some morbidity. The estimate for acute illness is 12 million cases per year with approximately 10,000 deaths. Most morbidity is in children. Sensitivity analysis suggests that infection estimates will not vary greatly with changes in parameter values but that morbidity estimates may be highly variable.

Entities:  

Mesh:

Year:  1997        PMID: 9236818     DOI: 10.1046/j.1365-3156.1997.d01-320.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  20 in total

1.  SURGICAL ASCARIASIS.

Authors:  M M Harjai
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Estimating the global distribution and disease burden of intestinal nematode infections: adding up the numbers--a review.

Authors:  Simon Brooker
Journal:  Int J Parasitol       Date:  2010-04-27       Impact factor: 3.981

3.  Early developmental stages of Ascaris lumbricoides featured by high-resolution mass spectrometry.

Authors:  Carlos Fernando Odir Rodrigues Melo; Cibele Zanardi Esteves; Rosimeire Nunes de Oliveira; Tatiane Melina Guerreiro; Diogo Noin de Oliveira; Estela de Oliveira Lima; Júlio César Miné; Silmara Marques Allegretti; Rodrigo Ramos Catharino
Journal:  Parasitol Res       Date:  2016-07-13       Impact factor: 2.289

4.  Inactivation of Ascaris suum by short-chain fatty acids.

Authors:  Michael A Butkus; Kelly T Hughes; Dwight D Bowman; Janice L Liotta; Michael B Jenkins; Michael P Labare
Journal:  Appl Environ Microbiol       Date:  2010-11-05       Impact factor: 4.792

5.  Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.

Authors:  Harry D Dawson; Ethiopia Beshah; Sandra Nishi; Gloria Solano-Aguilar; Motoko Morimoto; Aiping Zhao; Kathleen B Madden; Tonya K Ledbetter; J P Dubey; Terez Shea-Donohue; Joan K Lunney; Joseph F Urban
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Genes on chromosomes 1 and 13 have significant effects on Ascaris infection.

Authors:  Sarah Williams-Blangero; John L VandeBerg; Janardan Subedi; Mary Jo Aivaliotis; Dev Raj Rai; Ram Prasad Upadhayay; Bharat Jha; John Blangero
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 7.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  An Update on the Geohelminths: Ascaris lumbricoides, Hookworms, Trichuris trichiura, and Strongyloides stercoralis.

Authors:  Richard D. Pearson
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

Review 9.  A research agenda for helminth diseases of humans: the problem of helminthiases.

Authors:  Sara Lustigman; Roger K Prichard; Andrea Gazzinelli; Warwick N Grant; Boakye A Boatin; James S McCarthy; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

10.  Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial.

Authors:  Shally Awasthi; Richard Peto; Simon Read; Susan M Richards; Vinod Pande; Donald Bundy
Journal:  Lancet       Date:  2013-03-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.